Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Oncology
Biotech
Merck KGaA taps BenevolentAI, Exscientia for AI drug discovery
The three-target deals are collectively worth more than $30 million upfront and $1 billion in potential milestones.
Nick Paul Taylor
Sep 20, 2023 6:00am
Singapore's HiRO snaps up US oncology CRO Courante
Sep 6, 2023 3:05pm
Verastem bags options on GenFleet RAS programs to grow pipeline
Aug 28, 2023 10:30am
PicnicHealth enters the oncology field with AstraZeneca collab
Aug 23, 2023 4:30am
Aravive, weeks from liquidation, lays off 70% of its staff
Aug 22, 2023 8:50am
Letter of the day for Alphabet's Verily is O for OneOncology
Aug 17, 2023 4:30am
More News
Gilead, Tentarix ink $66M oncology, inflammatory disease deal
Aug 15, 2023 10:22am
Moderna plots lung cancer trial for Merck-partnered vaccine
Aug 2, 2023 3:28pm
Roche inks KSQ deal to expand stable of synthetic lethal assets
Jul 13, 2023 9:20am
Leal Health adds FDA-approved cancer treatment decision support
Jun 22, 2023 4:30am
See more stories